Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Apr 1;112(4):423-424.
doi: 10.1093/jnci/djz138.

RE: Universal Tumor DNA BRCA1/2 Testing of Ovarian Cancer: Prescreening PARPi Treatment and Genetic Predisposition

Federica Tomao, Pierluigi Benedetti Panici, Silverio Tomao
Comment

RE: Universal Tumor DNA BRCA1/2 Testing of Ovarian Cancer: Prescreening PARPi Treatment and Genetic Predisposition

Federica Tomao et al. J Natl Cancer Inst. .
No abstract available

PubMed Disclaimer

Comment in

  • Response to Tomao, Panici, and Tomao.
    Vos JR, Ligtenberg MJL, Hoogerbrugge N. Vos JR, et al. J Natl Cancer Inst. 2020 Apr 1;112(4):425. doi: 10.1093/jnci/djz140. J Natl Cancer Inst. 2020. PMID: 31287552 Free PMC article. No abstract available.

Comment on

References

    1. Vos JR, Fakkert IE, de Hullu JA, et al. Universal tumor DNA BRCA1/2 testing of ovarian cancer: prescreening PARPi treatment and genetic predisposition. J Natl Cancer Inst. 2020;112(2):161–169. - PMC - PubMed
    1. Capoluongo E, Ellison G, López-Guerrero JA, et al. Guidance statement on BRCA1/2 tumor testing in ovarian cancer patients. Semin Oncol. 2017;44(3):187–197. doi:10.1053/j.seminoncol.2017.08.004. - PubMed
    1. Cancer Genome Atlas Research Network. Integrated genomic analysis of ovarian carcinoma. Nature. 2011;474(7353):609–615. - PMC - PubMed
    1. Weren RD, Mensenkamp AR, Simons M, et al. Novel BRCA1 and BRCA2 tumor test as basis for treatment decisions and referral for genetic counselling of patients with ovarian carcinomas. Hum Mutat. 2017;38(2):226–235. - PMC - PubMed
    1. Vergote I, Banerjee S, Gerdes AM, et al. Current perspectives on recommendations for BRCA genetic testing in ovarian cancer patients. Eur J Cancer. 2016;69:127–134. - PubMed

LinkOut - more resources